Latest Revenue Forecast News

EVZ Limited has issued earnings guidance for the first half of FY2026, forecasting revenue between $60 million and $65 million and a notable rise in EBITDA, reflecting operational improvements.

The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.

SKS Technologies has landed its largest data centre contract yet, a $130 million project in Melbourne, lifting its total work on hand to $304 million and prompting an upward revision of its FY26 revenue guidance.

SportsHero has officially launched its HeroPlay mobile gaming platform in Indonesia through a partnership with Indosat Ooredoo Hutchison, offering over 600 instantly playable HTML5 games to nearly 99 million potential users.

Acusensus Limited has raised its FY26 revenue guidance to $83-$87 million, driven by significant new contracts in the US and New Zealand and expansions in Australia. This upgrade signals strong momentum in the company’s AI-powered road safety enforcement business.

Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.

Wagners Holding Company Limited reported a strong FY25 with profits more than doubling, driven by robust construction demand in Southeast Queensland and growth in composite fibre technologies. The company raised $30 million to expand its concrete plants and composite production capacity, positioning for further growth in FY26.

Monadelphous Group Limited has raised its revenue guidance for 2025, buoyed by strong contract awards and elevated activity across its engineering and construction divisions.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Antilles Gold Limited has released an updated financial analysis for its Nueva Sabana copper-gold mine in Cuba, highlighting improved project economics and a construction start slated for late 2025. The study reflects higher metal prices and revised costs, underpinning a strong net profit and positive cash flow outlook.

COSOL Limited reports a $7-8 million revenue shortfall in H1 FY26 amid macroeconomic pressures but pivots towards higher-margin Asset Management as a Service contracts and cost efficiencies to stabilize performance.